| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q |
| P8608 | Fatcat ID | release_jgvwt5qeuja3fitoniearbelje |
| P698 | PubMed publication ID | 9635524 |
| P50 | author | Carol Louik | Q42773707 |
| Lynn Rosenberg | Q55454936 | ||
| P2093 | author name string | Shapiro S | |
| P2860 | cites work | Aspirin use and reduced risk of fatal colon cancer | Q34567474 |
| Mechanism of inhibition of tumour growth by aspirin and indomethacin | Q36042640 | ||
| Prostaglandins and cancer: A review of tumor initiation through tumor metastasis | Q40129008 | ||
| Nonsteroidal antiinflammatory drugs and human cancer. Report of an interdisciplinary research workshop | Q41012103 | ||
| A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. | Q41145531 | ||
| Nonsteroidal antiinflammatory drugs and colorectal cancer | Q41341585 | ||
| Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer | Q41428926 | ||
| Nonsteroidal antiinflammatory drugs and colorectal cancer. | Q52882781 | ||
| Aspirin and the Risk of Colorectal Cancer in Women | Q57751820 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2326-2333 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. | |
| P478 | volume | 82 |
| Q37078077 | 11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis |
| Q28195221 | A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin |
| Q37191009 | Acetylsalicylic Acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators |
| Q24250572 | Anti-inflammatory agents for preventing the progression of cervical intraepithelial neoplasia |
| Q40605372 | Anti-lymphoma effect of naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma |
| Q34822109 | Are there two sides to colorectal cancer? |
| Q73672336 | Aspirin against cancer |
| Q34584944 | Aspirin dose and duration of use and risk of colorectal cancer in men. |
| Q28171138 | Aspirin-induced mucosal cell death in human gastric cells: evidence supporting an apoptotic mechanism |
| Q55312563 | Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies. |
| Q86969849 | COX-2 expression in canine anal sac adenocarcinomas and in non-neoplastic canine anal sacs |
| Q35552253 | Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study |
| Q53347864 | Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours. |
| Q33652932 | Colorectal cancer: molecules and populations |
| Q37422332 | Comparative efficacy of 5flourouracil/calcium leucovorine versus 5flourouracil/calcium leucovorine plus oxaliplatin in the adjuvant treatment of colonic carcinoma in Kashmir |
| Q59481265 | Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized |
| Q35769876 | Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer. |
| Q35574131 | Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. |
| Q37726379 | Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs. |
| Q28199809 | Do older adults using NSAIDs have a reduced risk of colorectal cancer? |
| Q28210611 | Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies |
| Q34263014 | Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials |
| Q28195714 | Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors |
| Q30545576 | Epithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis |
| Q40958587 | Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells |
| Q34047699 | Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study |
| Q34372773 | Inflammation, carcinogenesis and cancer |
| Q30486725 | Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans |
| Q47367905 | Inhibitory Effect of Aspirin on Cholangiocarcinoma Cells |
| Q28188848 | Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer |
| Q53228950 | Luteolin supplementation adjacent to aspirin treatment reduced dimethylhydrazine-induced experimental colon carcinogenesis in rats. |
| Q34165563 | Meta-analyses of colorectal cancer risk factors. |
| Q28192687 | NSAIDs and gastrointestinal cancer prevention |
| Q34027881 | Nonsteroidal anti-inflammatory drugs and prevention of colorectal cancer |
| Q34997948 | Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2. |
| Q28192323 | Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression |
| Q34756048 | Primary prevention of colorectal cancer: diet and drugs |
| Q92759129 | Quantitative risk of positive family history in developing colorectal cancer: A meta-analysis |
| Q48192569 | Re: Trends in reported incidence of primary malignant brain tumors in children in the United States |
| Q37324216 | Regular aspirin use and breast cancer risk in US Black women |
| Q24803838 | Regular aspirin use and lung cancer risk |
| Q24801805 | Regular use of aspirin and pancreatic cancer risk |
| Q30822060 | Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease |
| Q28196301 | Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study |
| Q35050873 | Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use. |
| Q58699234 | Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients? |
| Q28165741 | Use of NSAIDs for the Chemoprevention of Colorectal Cancer |
| Q37306239 | Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African Americans |
| Q73329564 | Variation in cyclooxygenase expression levels within the colorectum |
| Q53358485 | [NSAID, type 2 cyclo-oxygenase inhibitors and pancreatic carcinogenesis]. |
Search more.